3Kashiwai T,Tada H,Asahi K,et al. Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' ophthalmopathy [J]. Endocr J, 1995,42: 405 - 412.
4Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for heperthyroidism and the course of Graves' ophthalmopathy[J ]. N Engl J Med, 1998,8,338: 73 - 78.
5Cheng TC, Huang KM, Hakn YL, et al. Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalampathy[J]. Acta ophthalmol Scan, 1997, 75: 301 - 304.
6Baschieri L, Antonelli A, Nardi S, et al. Intravenous lannoglobulin versus corticosteroid intreatment of Graves ' ophthalimpathy [ J ] . Thyroid, 1997,7 ( 4 ): 579 - 585.
7Sakane N, Yoshida T, Shimatsu A, et al. Octreotide and bromocriptine suppress thyroid horome levels and thyroid nodule in an acromegalinc patients with nontoxic autonoamus goiter[J].Endoer J, 1997, 44:305 -310.
